ES2052210T3 - Pelicula compuesta para el tratamiento de superficies y procedimientos de fabricacion correspondientes. - Google Patents

Pelicula compuesta para el tratamiento de superficies y procedimientos de fabricacion correspondientes.

Info

Publication number
ES2052210T3
ES2052210T3 ES90402157T ES90402157T ES2052210T3 ES 2052210 T3 ES2052210 T3 ES 2052210T3 ES 90402157 T ES90402157 T ES 90402157T ES 90402157 T ES90402157 T ES 90402157T ES 2052210 T3 ES2052210 T3 ES 2052210T3
Authority
ES
Spain
Prior art keywords
treatment
composite film
manufacturing procedures
corresponding manufacturing
pharmaceutically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90402157T
Other languages
English (en)
Inventor
Jean-Louis Gueret
Francoise Lebreton
Jean-Claude Contamin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Application granted granted Critical
Publication of ES2052210T3 publication Critical patent/ES2052210T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)

Abstract

LA PELICULA COMPUESTA SEGUN EL INVENTO ESTA CONSTITUIDA POR UNA CAPA OCLUSIVA Y POR UNA CAPA DE DEPOSITO CONSTITUIDA POR UNA MATRIZ DE POLIMERO DE SILICONA QUE CONTIENE UNA FASE ACUOSA GELIFICADA COSMETICAMENTE Y/O FARMACEUTICAMENTE ACTIVA A MODO DE INCLUSIONES DISPERSAS, ESTANDO ASOCIADO EL CONJUNTO A UNA PROTECCION AMOVIBLE. LA MATRIZ CONSTA DE UNA TRAMA POR EL LADO OPUESTO A LA CAPA OCLUSIVA. PUDIENDO APLICARSE ESTA PELICULA SOBRE LA PIEL PARA HACER PENETRAR POR TRANSDERMIA SUSTANCIAS COSMETICAMENTE O FARMACEUTICAMENTE ACTIVAS. EL INVENTO SE REFIERE IGUALMENTE A UNOS PROCEDIMIENTOS DE PREPARACION DE ESTAS PELICULAS.
ES90402157T 1989-08-11 1990-07-26 Pelicula compuesta para el tratamiento de superficies y procedimientos de fabricacion correspondientes. Expired - Lifetime ES2052210T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8910825A FR2650747B1 (fr) 1989-08-11 1989-08-11 Film composite pour traitement cutane local et procedes de fabrication correspondants

Publications (1)

Publication Number Publication Date
ES2052210T3 true ES2052210T3 (es) 1994-07-01

Family

ID=9384665

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90402157T Expired - Lifetime ES2052210T3 (es) 1989-08-11 1990-07-26 Pelicula compuesta para el tratamiento de superficies y procedimientos de fabricacion correspondientes.

Country Status (7)

Country Link
US (1) US5100672A (es)
EP (1) EP0412869B1 (es)
JP (3) JP3099238B2 (es)
CA (1) CA2023127C (es)
DE (1) DE69008456T2 (es)
ES (1) ES2052210T3 (es)
FR (1) FR2650747B1 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681555A (en) * 1991-04-22 1997-10-28 Gleich; Gerald J. Method for the treatment of bronchial asthma by parenteral administration of anionic polymers
US5498410A (en) * 1991-04-22 1996-03-12 Gleich; Gerald J. Method for the treatment of eosinophil-associated conditions with anionic polymers
US5807364A (en) 1992-08-17 1998-09-15 Weyerhaeuser Company Binder treated fibrous webs and products
FR2706143B1 (fr) 1993-06-07 1995-08-11 Oreal Procédé de moulage d'une composition de maquillage et produit de maquillage obtenu.
US5451407A (en) * 1993-06-21 1995-09-19 Alza Corporation Reduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug
JPH07206710A (ja) * 1994-01-21 1995-08-08 Nitto Denko Corp 経皮投薬用テープ製剤
FR2735024B1 (fr) * 1995-06-08 1997-11-28 Sanofi Sa Dispositif d'administration cutanee d'un produit medicamenteux ou cosmetique.
FR2738744B1 (fr) * 1995-09-20 1997-10-24 Oreal Patch cosmetique ou dermo-pharmaceutique contenant dans une matrice polymerique au moins un compose actif en particulier instable en milieu oxydant et au moins un agent hydro-absorbant
US6063398A (en) * 1995-09-20 2000-05-16 L'oreal Cosmetic or dermopharmaceutical patch containing, in an anhydrous polymeric matrix, at least one active compound which is, in particular, unstable in oxidizing mediums, and at least one water-absorbing agent
US6022551A (en) * 1998-01-20 2000-02-08 Ethicon, Inc. Antimicrobial composition
US6248343B1 (en) 1998-01-20 2001-06-19 Ethicon, Inc. Therapeutic antimicrobial compositions
FR2776518B1 (fr) 1998-03-24 2002-11-29 Oreal Patch a matrice adhesive
FR2781668B1 (fr) * 1998-07-31 2001-06-01 Oreal Procede de traitement de la peau et patch pour la mise en oeuvre du procede
US6419935B1 (en) 1998-07-30 2002-07-16 L'oreal S.A. Cosmetic skin treatment method and cleansing treatment patch
US6342255B1 (en) * 1998-09-15 2002-01-29 Codex V S.R.L. Topical pharmaceutical compositions useful for the treatment of cutaneous of circulatory pathologies on inflammatory, immune, proliferative of degenerative basis
US6927315B1 (en) * 1999-07-30 2005-08-09 3M Innovative Properties Company Adhesive composite having distinct phases
FR2804870B1 (fr) * 2000-02-16 2002-08-16 Oreal Structure composite a matrice adhesive contenant un ou plusieurs actifs
FR2805720B1 (fr) 2000-03-03 2002-08-16 Oreal Dispositif comprenant un applicateur et/ou un organe d'essorage magnetique
ES2249451T3 (es) 2000-07-12 2006-04-01 L'oreal Dispositivo de acondicionamiento y/o de aplicacion que contiene unas fibras que comprenden por lo menos un cuerpo imantado o imantable.
FR2822711B1 (fr) * 2001-03-28 2003-06-13 Oreal Dispositif de traitement comportant une enveloppe definissant une cavite dans laquelle peut-etre engagee une partie du corps
FR2825246B1 (fr) * 2001-06-05 2004-06-04 Oreal Dispositif de conditionnement et/ou d'application comprenant des fibres comportant des particules capables d'absorber un liquide ou un compose en solution dans ce liquide ou de se dissoudre dans un liquide
US20030175328A1 (en) * 2002-03-06 2003-09-18 Adi Shefer Patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients into the skin
US20030175333A1 (en) * 2002-03-06 2003-09-18 Adi Shefer Invisible patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients onto the skin
EP1616551A1 (fr) 2004-07-13 2006-01-18 L'oreal Procédé de traitement cosmétique pour prévenir ou retarder les signes du vieillissement cutané
KR100788228B1 (ko) * 2004-08-11 2007-12-27 다이와보세키 가부시키가이샤 화장료 함침용 피부 피복 시트 및 그 제조 방법, 그리고이것을 사용한 페이스 마스크
GB0426255D0 (en) * 2004-11-30 2004-12-29 Younger Skin Ltd Improvements in and relating to products for skin treatment
FR2878745B1 (fr) 2004-12-07 2007-03-09 Oreal Dispositif transungeal
US20060147423A1 (en) * 2004-12-07 2006-07-06 Jean-Yves Legendre Transungual device
US7309809B2 (en) * 2005-02-26 2007-12-18 Xennovate Medical Llc Adhesive attachment and removal device
FR2884143B1 (fr) * 2005-04-08 2007-06-22 Millet Innovation Sa Timbre dermique rechargeable
JP2008004719A (ja) * 2006-06-22 2008-01-10 Matsushita Electric Ind Co Ltd 高電圧トランス
FR2909552B1 (fr) 2006-12-12 2009-11-20 Oreal Utilisation cosmetique de l'acide anisique pour favoriser la desquamation
DE102007006244B4 (de) * 2007-02-08 2012-03-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System zur Verabreichung wasserlöslicher Wirkstoffe
DE102014003731A1 (de) 2014-03-18 2015-09-24 Carl Freudenberg Kg Flächengebilde zur kontrollierten Freisetzung von Wirkstoffen

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725272A (en) * 1981-06-29 1988-02-16 Alza Corporation Novel bandage for administering beneficial drug
DE3333240A1 (de) * 1983-09-12 1985-03-28 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur transdermalen applikation von arzneimittelwirkstoffen
JPS60149699U (ja) * 1984-03-15 1985-10-04 株式会社トミー 作動玩具の動力伝達切換装置
US4687481A (en) * 1984-10-01 1987-08-18 Biotek, Inc. Transdermal drug delivery system
US4695464A (en) * 1984-10-09 1987-09-22 The Dow Chemical Company Sustained release dosage form based on highly plasticized cellulose ether gels
DE3586713T2 (de) * 1984-11-15 1993-05-13 Hercon Lab Vorrichtung zur kontrollierten abgabe von arzneimittelwirkstoffen.
EP0196769B1 (en) * 1985-02-25 1992-07-08 Rutgers, The State University of New Jersey A novel transdermal pharmaceutical absorption dosage unit
AU561608B1 (en) * 1985-11-04 1987-05-14 Paco Research Corp. Transdermal vasoactive delivery
US4749574A (en) * 1986-04-14 1988-06-07 Fujisawa Pharmaceutical Co., Ltd. Sustained-release transdermal delivery preparations
CA1272922A (en) * 1986-06-03 1990-08-21 Peter William Berry Drug delivery device, its preparation and use
IL86170A (en) * 1987-05-01 1992-12-01 Elan Transdermal Ltd Preparations and compositions comprising nicotine for percutaneous administration
FR2620914B1 (fr) * 1987-09-25 1991-11-08 Oreal Materiau en feuille pour realiser un traitement cutane ou capillaire, son procede de fabrication et articles realises en ce materiau

Also Published As

Publication number Publication date
JPH0383918A (ja) 1991-04-09
EP0412869A1 (fr) 1991-02-13
US5100672A (en) 1992-03-31
JPH11322537A (ja) 1999-11-24
JP3189121B2 (ja) 2001-07-16
JP2000229851A (ja) 2000-08-22
DE69008456T2 (de) 1994-12-15
JP3099238B2 (ja) 2000-10-16
CA2023127C (fr) 2000-11-07
EP0412869B1 (fr) 1994-04-27
CA2023127A1 (fr) 1991-02-12
FR2650747A1 (fr) 1991-02-15
FR2650747B1 (fr) 1994-02-11
DE69008456D1 (de) 1994-06-01

Similar Documents

Publication Publication Date Title
ES2052210T3 (es) Pelicula compuesta para el tratamiento de superficies y procedimientos de fabricacion correspondientes.
NO895172D0 (no) Fremgangsmaate for fremstilling av et transdermalt terapeutisk system med phytostigmin som virkestoff.
KR890701164A (ko) 피부침투성 치료 시스템
EP0251464A3 (en) Composition for the control of insects
PT81751B (pt) Processo para a preparacao de adesivos para aplicacao de medicamentos por via transdermica
ES2100133B1 (es) Aplicador de apositos adhesivos.
JPS59155268A (ja) 薬剤注入装置
PT92652A (pt) Processo para a preparacao de um sistema terapeutico transdermico contendo fisostigmina como ingrediente activo
ES2188907T3 (es) Dispositivo de soporte farmaceutico adecuado ppara la administracion de compuestos farmaceuticos a las superficies de las mucosas.
DE69025943D1 (de) Verwendung von Spiperone-derivate zur Immunosuppression
ATE133569T1 (de) Pflaster als therapeutisches system zur verabreichung von wirkstoffen an die haut mit einer abgestuften wirkstoffabgabe, verfahren zu seiner herstellung sowie verwendung
HK1079455A1 (en) Medical active agent patch optically less visible on skin
EP2785356B1 (en) Use of pullulan for alleviating the appearance of scars or scar tissue
KR101811937B1 (ko) 피부 마스킹재
WO1994025025A3 (de) Systeme zur kontrollierten abgabe von pilocarpin
ATE112174T1 (de) Superfizielles therapeutisches system mit einem gehalt an einem antineoplastischen wirkstoff, insbesondere 5-fluoruracil.
HUP9903348A2 (hu) Transzdermális terápiás rendszer (tts) drogfüggőség vagy drogmegszokás kezelésére alkalmas hatóanyagok adagolására
HUP0000045A2 (hu) Betametazonnal és hialuronsavval kezelt vékony ragtapasz pszoriázis, dermatitisz és dermatózis kezelésére
EP2257254B1 (de) Pflaster
CN113164263A (zh) 改进的皮肤替代物的粘附性、可拉伸性和皮肤替代物的顺应性
CO5011042A1 (es) Uso de una oxazolidinona para la fabricacion de un medicamento para administracion topica
CN213284951U (zh) 一种留置针防压疮贴
Köurlof et al. Radiation-Sterilized Split Skin: A new type of Biological Wound Dressing: A Preliminary Report
DE102008011566A1 (de) Pflaster
MX2022012512A (es) Ballena difusora desechable.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 412869

Country of ref document: ES